Validation of an HIV whole genome sequencing method for HIV drug resistance testing in an Australian clinical microbiology laboratory
Journal of Medical Virology · 2023-12 · 95 (12)
DOI: 10.1002/jmv.29273 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, online erschienen am 05.12.2023. Verfasst von Frances Jenkins und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases and Microbiology, Royal Prince Alfred Hospital, Sydney, Australia. Hauptthemen laut MEDLINE: HIV-1, HIV Infections, Anti-HIV Agents. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Wellcome Trust.
Abstract (Originalsprache)
Detection of HIV drug resistance (HIVDR) is vital to successful anti‐retroviral therapy (ART). HIVDR testing to determine drug‐resistance mutations is routinely performed in Australia to guide ART choice in newly diagnosed people living with HIV or in cases of treatment failure. In 2022, our clinical microbiology laboratory sought to validate a next‐generation sequencing (NGS)‐based HIVDR assay to replace the previous Sanger‐sequencing (SS)‐based ViroSeq. NGS solutions for HIVDR offer higher throughput, lower costs and higher sensitivity for variant detection. We sought to validate the previously described low‐cost probe‐based NGS method (veSEQ‐HIV) for whole‐genome recovery and HIVDR‐testing in a diagnostic setting. veSEQ‐HIV displayed 100% and 98% accuracy in major and minor mutation detection, respectively, and 100% accuracy of subtyping (provided > 1000 mapped reads were obtained). Pairwise comparison exhibited low inter‐and intrarun variability across the whole‐genome (Jaccard index [ J ] = 0.993; J = 0.972) and the Pol gene ( J = 0.999; J = 0.999), respectively. veSEQ‐HIV met all our pre‐set criteria based on WHO recommendations and successfully replaced ViroSeq in our laboratory. Scaling‐down veSEQ‐HIV to a limited batch size and sequencing on Illumina iSeq. 100, allowed easy implementation of the assay into the workflow of a small sequencing laboratory with minimal staff and equipment and the ability to meet clinically relevant test turn‐around times. As HIVDR‐testing moves from SS‐ to NGS‐based methods and new ART drugs come to market (particularly those with targets outside the Pol region), whole‐genome recovery using veSEQ‐HIV provides a robust, cost‐effective and “future‐proof” NGS method for HIVDR‐testing.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Infectious Diseases and Microbiology, Royal Prince Alfred Hospital, Sydney, Australia.
- The Kirby Institute, UNSW Australia, Sydney, Australia.
- Wellcome Centre for Human Genetics, University of Oxford, Oxford, UK.
- Department of Medical Sciences, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
- The Walter and Eliza Hall Institute of Medical Research, Advanced Genomics Facility, Melbourne, Australia.
- Department of Clinical Immunology and Allergy, Royal Prince Alfred Hospital, Sydney, Australia.
ORCID-Profile: Frances Jenkins, Sebastiaan J van Hal
Förderung
- Wellcome Trust
Zitieren
APA
Jenkins, F., Le, T., Farhat, R., Pinto, A., Anzari, A., Bonsall, D., Golubchik, T., Bowden, R., Lee, F. J., & van Hal, S. J. (2023). Validation of an HIV whole genome sequencing method for HIV drug resistance testing in an Australian clinical microbiology laboratory. Journal of Medical Virology, 95(12). https://doi.org/10.1002/jmv.29273
Vancouver
Jenkins F, Le T, Farhat R, Pinto A, Anzari A, Bonsall D, et al. Validation of an HIV whole genome sequencing method for HIV drug resistance testing in an Australian clinical microbiology laboratory. Journal of Medical Virology. 2023;95(12). doi:10.1002/jmv.29273
BibTeX
@article{Jenkins2023,
author = {Jenkins, Frances and Le, Thomas and Farhat, Rima and Pinto, Angie and Anzari, Azim and Bonsall, David and Golubchik, Tanya and Bowden, Rory and Lee, Frederick J and van Hal, Sebastiaan J},
title = {Validation of an HIV whole genome sequencing method for HIV drug resistance testing in an Australian clinical microbiology laboratory},
journal = {Journal of Medical Virology},
year = {2023},
volume = {95},
number = {12},
doi = {10.1002/jmv.29273}
}
EUVIMED